LAVA Medtech Acquisition Corp.

LAVA Medtech Acquisition Corp. (Nasdaq: LVAC) is a blank-check company formed to pursue a business combination in the medical technology sector. Sponsored by LAVA Medtech Sponsor LLC, the company completed its initial public offering in 2021, targeting innovative medtech businesses positioned to benefit from continued advances in healthcare delivery and device development. The May 2023 Form 8-K filing, carrying accession number 0001213900-23-034639, reflects a material corporate development during the company's search period. As of the filing date, LVAC remained in the target-identification phase of its lifecycle. Investors and analysts seeking full filing history, deal timelines, and sector comparables for LVAC can sign up for complete data access at SpacDesk.